MarginsXMarginsX
Home › Markets › Health Care › MO

Altria Group Inc. (MO)

MO trades on NYSE in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$78.90
+0.33% on the day
Market cap
$131.2B
Large cap
Revenue · 2025
$23.3B
-3.1% on 2024
Net income · 2025
$6.9B
29.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/764180/000076418026000017/0000764180-26-000017-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerMO on NYSE
SectorHealth Care
Industry Medicinal Chemicals and Botanical Products
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000764180
SEC industry codeCigarettes
Incorporated inVA

Financials · 2025

LineValue
Revenue$23.3B
Net income$6.9B
Operating income$9.9B
Net margin29.8%
Operating margin42.5%
Revenue growth-3.1%
Cash$4.5B
Total assets$35.0B
P/E (computed)18.9×
P/S (computed)5.6×

Warning signs

Cash runway
Cash-flow positive
$2.7B cash at September 30, 2026
Share count, 1 year
-0.9%
2025-10-22 to 2026-10-21 · -5.9% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$2.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$2.7B cash; operating cash flow $2.4B a quarter.Report 2026-09-30
Shares outstanding1,663,436,915 (2026-10-21); 1,678,671,552 a year earlier; 1,768,646,674 three years earlier.Cover page 2026-10-21
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-10-29
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-06-16
AuditorPricewaterhouseCoopers LLP, Richmond, Virginia, United StatesPCAOB Form AP 2026-02-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $101K, sold $2.4M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$6.1B$2.5B$3.1B$2.7B$24.1B$23.5B10-Q 2026-10-29
Q2 2026
2026-06-30
$6.1B$2.3B$719.0M$2.4B$24.6B$23.5B10-Q 2026-07-30
Q1 2026
2026-03-31
$5.4B$2.2B$2.3B$3.5B$24.6B$23.4B10-Q 2026-04-30
Q4 2025
2025-12-31
$5.8B$1.1B$3.3B$4.5B$25.7B$23.3B10-K 2026-02-25
Q3 2025
2025-09-30
$6.1B$2.4B$3.1B$3.5B$25.7B$23.4B10-Q 2026-10-29
Q2 2025
2025-06-30
$6.1B$2.4B$205.0M$1.3B$24.7B$23.6B10-Q 2026-07-30
Q1 2025
2025-03-31
$5.3B$1.1B$2.7B$4.7B$26.1B$23.7B10-Q 2026-04-30
Q4 2024
2024-12-31
$6.0B$3.0B$3.3B$3.1B$24.9B$24.0B10-K 2026-02-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-10-29
Latest annual report10-K/A2026-05-27
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-02

Source: SEC EDGAR submissions feed, 1,006 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.3%
1 month+9.9%
3 months+20.8%
Year to date+36.4%
1 year+36.0%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medicinal Chemicals and Botanical Products

TickerCompanyPriceDayMarket cap
BTIBritish American Tobacco Industries p.l.c. Common Stock ADR$62.11+0.36%$134.2B
PMPhilip Morris International Inc$196.04-1.47%$305.6B
DFTXDefinium Therapeutics Inc. Common Shares$30.16-5.99%$4.1B
RGCRegencell Bioscience Holdings Limited$4.72-4.45%$2.3B
TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.33-5.23%$2.0B
RLXRLX Technology Inc.$1.53-1.92%$1.9B
CRONCronos Group Inc. Common Share$3.27-3.25%$1.2B
OBIOOrchestra BioMed Holdings Inc.$7.12-1.79%$560.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier